✦ LIBER ✦

Contribution of cyclodextrins in the development of different pharmaceutical formulations of a new matrix metalloproteinase inhibitor

✍ Scribed by B. Evrard; P. Bertholet; M. Gueders; M. Piette; G. Piel; D. Cataldo; L. Delattre

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Matrix metalloproteinase–inhibitor inter

✍ Luis A. Alcaraz; Lucia Banci; Ivano Bertini; Francesca Cantini; Antonio Donaire; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB

The Development of a Large-Scale Synthes

✍ Chang, Sou-Jen; Fernando, Dilinie; Fickes, Michael; Gupta, Ashok K.; Hill, David 📂 Article 📅 2002 🏛 American Chemical Society 🌐 English ⚖ 86 KB

Matrix Metalloproteinase Inhibitor COL-3

✍ Parvathy, Subramanian S.; Masocha, Willias 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 596 KB

Clinical Trials of a Matrix Metalloprote

✍ ROBERT A. ASHLEY; THE SDD CLINICAL RESEARCH TEAM 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB

The Role of Matrix Metalloproteinases an

✍ Mroczko, Barbara ;Groblewska, Magdalena ;Barcikowska, Maria 📂 Article 📅 2013 🏛 IOS Press 🌐 English ⚖ 93 KB

Intraluminal Thrombus has a Selective In

✍ Khan, Junaid A.; Abdul Rahman, M.N.A.; Mazari, F.A.K.; Shahin, Y.; Smith, G.; Ma 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 507 KB